Table 1.
Clinical and experimental parameters
Controls | Schizophrenia | ||
---|---|---|---|
n | 25 | 29 | |
female | 5 | 4 | |
male | 20 | 25 | |
CPZ (mg/day) | 451 ± 273 | ||
duration of illness (months) | 15 ± 10.5 | ||
IQ | 98.92 10.12 | 101.1 14.7 | p=0.64 |
PSES | 2.79 1.38 | 2.81 0.94 | p=0.96 |
age (years) | 43.68 ± 7.62 | 46.59 ± 9.504 | p=0.30 |
education (years) | 14.35 ± 1.843 | 13.75 ± 2.51 | p=0.16 |
motion (mm) | 0.777 ± 0.13 | 0.786 ± 0.184 | p=0.84 |
CPZ = chlorpromazine equivalent daily dosage; PSES = Parental social economic status